Despite being mainly composed of terminally differentiated myocytes that cannot re-enter the cell cycle, the heart is not a postmitotic organ and maintains some capacity to form new parenchymal ...
Three papers are on iPS cells: Ken Chien and colleagues report the generation of iPS cells from murine ventricular myocytes and their ... acid could enhance cardiac differentiation of iPS cells ...
News Medical on MSN9d
Stem cell-derived heart patches show promise for heart failure treatmentInnovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...
A patient who received the world’s first transplant of cardiac muscle cells using artificially derived stem cells known as iPS cells this month is in stable condition, an Osaka University team ...
in contrast to the unique potential of pluripotent stem cell therapy. IPS HEART has also been awarded Rare Pediatric Drug Designation for Duchenne cardiomyopathy as ISX9-CPCs have been shown to ...
Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...
in contrast to the unique potential of pluripotent stem cell therapy. IPS HEART has also been awarded Rare Pediatric Drug Designation for Duchenne cardiomyopathy as ISX9-CPCs have been shown to make ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback